A medical device alert has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA) for all healthcare workers who are responsible for patients using Accu-chek Insight insulin pumps.

Manufactured by Roche Diabetes Care, the alert warns that audible and/or vibration alarms might not function, which may lead to hyperglycaemia if the user doesn’t see the notification message on the pump.

Click here for full details.

Recommended

New app pushes self-care agenda

The app directs consumers to the pharmacy rather than the GP for common healthcare ailments.

Immuno-oncology revolution underway

Advances in immuno-oncology (IO) are revolutionising the standard of care for many types of cancer.